ISU
Home
ISURF/OIPTT
Home
ISURFtech
Home
Advanced
Search
RSS
Feeds
Probiotic treatment of gut inflammation
Category(s):
For Information, Contact:
Dario Valenzuela
Senior Commercialization Manager, Life Sciences
515-294-4740
licensing@iastate.edu
Web Published:
8/9/2017
ISURF #
4644
Summary:
A screening methodology to identify potentially beneficial probiotic strains and strains identified using such methodology.

Development Stage:

Description:
Probiotics are live organisms that confer beneficial health effects to human and animals. The use of probiotics to treat gut inflammation is widespread and has been ongoing for decades. Critically, none of the probiotics used for this purpose have been approved by any governmental regulatory body principally because there is no defined mechanism by which they work. This prevents any approval by the FDA.
 
ISU researchers have discovered new biochemical properties in some probiotics that would explain how some of them work to reduce gut inflammation. In addition, they have developed a screening method to identify potentially beneficial probiotic strains with the desired biochemical properties. Use of the screening methodology yielded specific strains that are available for licensing.

Group:
Advantage:
• New discovery of a microbial endocrinology-based mechanism
• Screening methodology to identify potentially beneficial probiotic strains.
• Probiotic strains available for licensing.
Patent Information:
*To see the full version of the patent(s), follow the link below, then click on "Images" button.


Direct Link: